Inhibition of 11β–hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans-Reference-Cited by-同舟云学术

Inhibition of 11β–hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans

Published:2009-04-01 Issue:4 Volume:119 Page:876-885
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Zhang Ming-Zhi,Xu Jie,Yao Bing,Yin Huiyong,Cai Qiuyin,Shrubsole Martha J.,Chen Xiwu,Kon Valentina,Zheng Wei,Pozzi Ambra,Harris Raymond C.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference53 articles.

1. Prostaglandin E 2 Promotes Colon Cancer Cell Growth Through a G s -Axin-ß-Catenin Signaling Axis

2. The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis

3. A Randomized Trial of Aspirin to Prevent Colorectal Adenomas

4. A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment;Signal Transduction and Targeted Therapy;2024-02-21

2. In Silico Evaluation of the Antioxidant, Anti-Inflammatory, and Dermatocosmetic Activities of Phytoconstituents in Licorice (Glycyrrhiza glabra L.);Cosmetics;2023-04-25

3. Integrated bioinformatics analysis to identify the key gene associated with metastatic clear cell renal cell carcinoma;Medical Oncology;2022-06-18

4. Can non-cholesterol sterols indicate the presence of specific dysregulation of cholesterol metabolism in patients with colorectal cancer?;Biochemical Pharmacology;2022-02

5. Myeloid cyclooxygenase-2/prostaglandin E2/E-type prostanoid receptor 4 promotes transcription factor MafB-dependent inflammatory resolution in acute kidney injury;KIDNEY INT;2022